Psyence Biomedical Ltd. (PBM) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Psyence Biomedical Ltd. (PBM) Earnings Overview
As of September 24, 2026, Psyence Biomedical Ltd. (PBM) reported trailing twelve-month net income of -$26M, reflecting -100.0% year-over-year growth. The company earned $-1.92 per diluted share over the past four quarters.
Looking at the long-term picture, PBM's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2021.
Psyence Biomedical Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$394M net income), MNMD (-$238M net income), ATAI (-$668M net income, -16142.0% margin), PBM has comparable earnings metrics. Compare PBM vs CMPS →
PBM Earnings vs Peers
Earnings metrics vs comparable public companies
PBM Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$7M | -785.6% | -$6M | $0.00 | - | - |
| 2024 | $1M | +102.0% | -$4M | $1.78 | - | - |
| 2023 | -$51M | -738.3% | -$3M | $-7.85 | - | - |
| 2022 | $8M | -2.6% | -$4M | $-0.64 | - | - |
| 2021 | $8M | - | $-334,290 | $0.25 | - | - |
Download Data
Export PBM earnings history in CSV or JSON format
Free sign-in required to download data
PBM Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PBM — Frequently Asked Questions
Quick answers to the most common questions about buying PBM stock.
What is PBM earnings per share (EPS)?
PBM trailing twelve-month (TTM) diluted EPS is $-1.92, reflecting -100.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Psyence Biomedical Ltd.'s net income?
Psyence Biomedical Ltd. (PBM) trailing twelve-month net income is $-26M as of 2025. Earnings declined -100.0% year-over-year.
Is PBM profitable?
PBM is not currently profitable on a TTM basis, reporting a net loss of $-26M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PBM's earnings growth rate?
PBM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are PBM's profit margins?
Psyence Biomedical Ltd. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -58.6%.
Is PBM growing earnings?
PBM earnings are declining — EPS fell -100.0% year-over-year. TTM net income dropped to $-26M. This contrasts with the 5-year CAGR of N/A.
What was PBM's best earnings year?
Psyence Biomedical Ltd.'s highest annual net income on record is $8M, achieved in fiscal year 2021. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were PBM's earnings last quarter?
PBM's most recent reported quarter was Q3 2023. Net income was $-25M with diluted EPS of $-1.85. For a full breakdown of all quarters, see the quarterly earnings table on this page.